We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Labguru Announces $1M Pro-bono Program for COVID-19 Treatment Developers

Product News   Apr 16, 2020

 
Labguru Announces $1M Pro-bono Program for COVID-19 Treatment Developers
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Moderna’s COVID-19 Vaccine Retains Neutralizing Activity Against Variants

Product News

Moderna Inc today announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of SARS-CoV-2.

READ MORE

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Product News

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

READ MORE

Thermo Extends SARS-CoV-2 Program to Support Research on New Virus Strains

Product News

Company makes subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE